The US Food and Drug Administration (FDA) has granted clearance to SpliceBio’s investigational new drug (IND) application to begin the trial of a protein splicing gene therapy, SB-007, designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback